METHOD OF PREVENTING OR REDUCING ADVERSE REACTIONS TO PROTAMINE USING A THROMBOXANE A2 RECEPTOR ANTAGONIST

A method is provided for preventing, reducing or reversing adverse reactions, such as pulmonary hypertension produced when protamine interacts with heparin, by administering a thromboxane A2 receptor antagonist.

Saved in:
Bibliographic Details
Main Authors SCHUMACHER; WILLIAM A, GROVER; GARY J, OGLETREE; MARTIN L, FRIEDHOFF; LAWRENCE T
Format Patent
LanguageEnglish
Published 19.11.1991
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A method is provided for preventing, reducing or reversing adverse reactions, such as pulmonary hypertension produced when protamine interacts with heparin, by administering a thromboxane A2 receptor antagonist.
Bibliography:Application Number: US19880179694